Current and future circulating biomarkers for cardiac amyloidosis
نویسندگان
چکیده
منابع مشابه
Current perspectives on cardiac amyloidosis.
Amyloidosis represents a group of diseases in which proteins undergo misfolding to form insoluble fibrils with subsequent tissue deposition. While almost all deposited amyloid fibers share a common nonbranched morphology, the affected end organs, clinical presentation, treatment strategies, and prognosis vary greatly among this group of diseases and are largely dependent on the specific amyloid...
متن کاملThe Future of Cardiac Biomarkers
Cardiac biomarkers such as CK-MB, troponins, and myoglobin provide the basis for the diagnosis of acute myocardial infarction (AMI) through identifi cation of the necrosis of myocardial cells in the heart. For emergency physicians, or any clinician evaluating and treating patients presenting to the hospital with acute coronary syndrome (ACS), ischemic changes on the 12-lead electrocardiogram or...
متن کاملCurrent and future biomarkers in colorectal cancer
Colorectal cancer (CRC), one of the leading causes of death among cancer patients, is a heterogeneous disease and is characterized by diversions in multiple molecular pathways throughout its evolutionary process. To date, specific mutations in RAS and RAF genes are tested in everyday clinical practice along with mismatch repair gene deficiency, serving either as prognostic or predictive biomark...
متن کاملCardiac biomarkers: past, present and future.
Accurate recognition of signs and symptoms and prompt diagnosis of myocardial infarction are essential for preserving myocardial function and saving lives. However, measurements of cardiac enzymes such as creatine kinase, lactate dehydrogenase, and their isoenzymes do not always provide accurate clinical diagnosis, particularly in patients with other concomitant diseases. Recently, alternative ...
متن کاملBiomarkers for depression: recent insights, current challenges and future prospects
A plethora of research has implicated hundreds of putative biomarkers for depression, but has not yet fully elucidated their roles in depressive illness or established what is abnormal in which patients and how biologic information can be used to enhance diagnosis, treatment and prognosis. This lack of progress is partially due to the nature and heterogeneity of depression, in conjunction with ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Pharmacologica Sinica
سال: 2018
ISSN: 1671-4083,1745-7254
DOI: 10.1038/aps.2018.38